The Actos Settlement

Published: Sept. 28, 2015, 12:46 a.m.

Takeda Pharmaceutical Co. agreed to a $2.4 billion settlement to resolve bladder cancer claims tied to its Type 2 diabetes drug Actos. On past Ringler Radio shows, we have followed the litigation surrounding Actos.  On Ringler Radio, host Larry Cohen and co-host, Keith Christie join guest Attorney Frank Woodson, from the Beasley Allen Law Firm,  to discuss this billion dollar settlement, negotiating a settlement and the impact on future pharmaceutical litigation.